Literature DB >> 17005399

Myopathy in horses with pituitary pars intermedia dysfunction (Cushing's disease).

M Aleman1, J L Watson, D C Williams, R A LeCouteur, J E Nieto, G D Shelton.   

Abstract

Fifteen horses with pituitary pars intermedia dysfunction were studied. The horses were of various breeds and between 15 and 28 years of age. Control horses matched for breed and age were studied for comparison. Evaluations included complete blood cell count and serum biochemical analysis, electromyography, and gluteus medius muscle biopsies for histochemical, morphometric, and ultrastructural analysis. No differences were found between groups of horses on routine laboratory analysis or electromyography. We demonstrated that muscle wasting in diseased horses was the result of atrophy of types 2A and 2B muscle fibers and loss of type 2B myofibers. Mild non-specific non-inflammatory myopathic alterations such as myofiber size variation, internal nuclei, perimysial, endomysial and sarcoplasmic fat accumulation were observed. At the ultrastructural level, subsarcolemmal mitochondrial accumulation and increased lipid droplets were evident. Similar to other species, this study confirmed atrophy of type 2 fibers as the cause of muscle mass loss in horses with Cushing's disease.

Entities:  

Mesh:

Year:  2006        PMID: 17005399     DOI: 10.1016/j.nmd.2006.07.019

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  3 in total

1.  Clinical Implications and Hospital Outcome of Immune-Mediated Myositis in Horses.

Authors:  L Hunyadi; E A Sundman; P H Kass; D C Williams; M Aleman
Journal:  J Vet Intern Med       Date:  2017-01-02       Impact factor: 3.333

2.  Neuromyotonia in a horse.

Authors:  Luiza Stachewski Zakia; Mariana Isa Pocci Palumbo; Raffaella Bertoni Cavalcanti Teixeira; Luiz Antônio Lima Resende; Mauro Pereira Soares; José Paes de Oliveira-Filho; Rogério Martins Amorim; Alexandre Secorun Borges
Journal:  J Vet Intern Med       Date:  2018-12-03       Impact factor: 3.333

3.  Equine pituitary pars intermedia dysfunction: Identifying research priorities for diagnosis, treatment and prognosis through a priority setting partnership.

Authors:  Rebecca C Tatum; Cathy M McGowan; Rachel S Dean; Joanne L Ireland
Journal:  PLoS One       Date:  2021-01-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.